<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Traumatology and Orthopedics of Russia</journal-id><journal-title-group><journal-title xml:lang="en">Traumatology and Orthopedics of Russia</journal-title><trans-title-group xml:lang="ru"><trans-title>Травматология и ортопедия России</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2311-2905</issn><issn publication-format="electronic">2542-0933</issn><publisher><publisher-name xml:lang="en">Vreden National Medical Research Center of Traumatology and Orthopedics</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">17664</article-id><article-id pub-id-type="doi">10.17816/2311-2905-17664</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>CLINICAL STUDIES</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>КЛИНИЧЕСКИЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="zh"><subject>Clinical studies</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Histological Features of Fascial Fibromatosis in Patients with Rapidly Progressive Dupuytren’s Contracture</article-title><trans-title-group xml:lang="ru"><trans-title>Гистологические характеристики фасциального фиброматоза у пациентов с быстрым прогрессированием контрактуры Дюпюитрена</trans-title></trans-title-group><trans-title-group xml:lang="zh"><trans-title/></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-9914-8563</contrib-id><name-alternatives><name xml:lang="en"><surname>Shchudlo</surname><given-names>Nathalia A.</given-names></name><name xml:lang="ru"><surname>Щудло</surname><given-names>Наталья Анатольевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Med.)</p></bio><bio xml:lang="ru"><p>д-р мед. наук</p></bio><email>nshchudlo@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0003-3434-0372</contrib-id><name-alternatives><name xml:lang="en"><surname>Stupina</surname><given-names>Tatyana A.</given-names></name><name xml:lang="ru"><surname>Ступина</surname><given-names>Татьяна Анатольевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Dr. Sci. (Biol.)</p></bio><bio xml:lang="ru"><p>д-р биол. наук</p></bio><email>stupinasta@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5430-2045</contrib-id><name-alternatives><name xml:lang="en"><surname>Varsegova</surname><given-names>Tatyana N.</given-names></name><name xml:lang="ru"><surname>Варсегова</surname><given-names>Татьяна Николаевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><bio xml:lang="en"><p>Cand. Sci. (Biol.)</p></bio><bio xml:lang="ru"><p>канд. биол. наук</p></bio><email>varstn@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-4399-2973</contrib-id><name-alternatives><name xml:lang="en"><surname>Ostanina</surname><given-names>Daria A.</given-names></name><name xml:lang="ru"><surname>Останина</surname><given-names>Дарья Андреевна</given-names></name><name xml:lang="zh"><surname></surname><given-names></given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>ostaninadar@yandex.ru</email><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">National Ilizarov Medical Research Centre for Traumatology and Orthopedics</institution></aff><aff><institution xml:lang="ru">ФГБУ «Национальный медицинский исследовательский центр травматологии и ортопедии им. акад. Г.А. Илизарова» Минздрава России</institution></aff><aff><institution xml:lang="zh"></institution></aff></aff-alternatives><pub-date date-type="preprint" iso-8601-date="2025-07-17" publication-format="electronic"><day>17</day><month>07</month><year>2025</year></pub-date><pub-date date-type="pub" iso-8601-date="2025-09-15" publication-format="electronic"><day>15</day><month>09</month><year>2025</year></pub-date><volume>31</volume><issue>3</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><issue-title xml:lang="zh"/><fpage>111</fpage><lpage>120</lpage><history><date date-type="received" iso-8601-date="2025-01-23"><day>23</day><month>01</month><year>2025</year></date><date date-type="accepted" iso-8601-date="2025-05-06"><day>06</day><month>05</month><year>2025</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2025, Eco-Vector</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2025, Эко-Вектор</copyright-statement><copyright-statement xml:lang="zh">Copyright ©; 2025,</copyright-statement><copyright-year>2025</copyright-year><copyright-holder xml:lang="en">Eco-Vector</copyright-holder><copyright-holder xml:lang="ru">Эко-Вектор</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by-nc-nd/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://journal.rniito.org/jour/article/view/17664">https://journal.rniito.org/jour/article/view/17664</self-uri><abstract xml:lang="en"><p><bold>Background</bold><bold>.</bold> Research into the etiology and pathogenesis of palmar fascial fibromatosis remains relevant to this day. However, the data on the histogenetic nature of its rapid progression and histological predictors of its recurrence are absent in the literature.</p> <p><bold>The</bold><bold> </bold><bold>aim</bold><bold> </bold><bold>of</bold><bold> </bold><bold>the</bold><bold> </bold><bold>study</bold><bold> </bold>— to perform a comparative analysis of the tissue composition and perforating arteries of the palmar aponeurosis in patients with rapid and typical progression of Dupuytren’s contracture.</p> <p><bold>Methods</bold><bold>.</bold> A total of 222 medical records of patients operated on in the period from 2014 to 2019 were analyzed. The development period of Dupuytren’s contracture (DC) in the largest group (n = 88) — from 3 to 8 years — was defined as typical; the development of DC in two years or less (n = 41) was interpreted as rapid. Histomorphometry of the surgical material was performed in cases of rapid (n = 20, Group 1) and typical (n = 25, Group 2) progression of DC. We used the fragments of palmar aponeurosis from conditionally healthy people (n = 5) as control samples. These were excised during surgical treatment of the hand wounds.</p> <p><bold>Results</bold><bold>.</bold> The median content of hyperplastic connective tissue was statistically significantly higher in Group 1 (p &lt; 0.05), though the indicator varied widely in both groups. Group 1 showed a statistically significantly higher proportion of microvasculature vessels, including pathologically altered and newly formed ones (CD34+). Histomorphometry of the perforating arteries of the palmar aponeurosis showed that, compared with the control samples, the outer diameter in medium-sized arteries in patients of Groups 1 and 2 is larger by 4% (p &lt; 0.05) and 12.5% (p &lt; 0.01), respectively. The lumen diameter is 30% smaller in Group 1 (p &lt; 0.01) and 31% larger in Group 2 (p &gt; 0.05). In large-caliber arteries in Groups 1 and 2, the outer diameter is smaller by 18% (p &lt; 0.01) and 17% (p &gt; 0.05) compared to the control, and the lumen diameter is smaller by 52% (p = 0.00) and 18% (p &gt; 0.05), respectively.</p> <p><bold>Conclusion</bold><bold>.</bold> Despite the shorter duration of the disease, patients with rapidly progressive Dupuytren’s contracture showed an increase in the number of pathologically altered microcirculatory vessels, as well as more pronounced stenotic remodeling of the perforating arteries of the palmar aponeurosis, which verifies early vascular aging. Histologic predictors of postoperative recurrence should be assessed individually.</p></abstract><trans-abstract xml:lang="ru"><p><bold>Актуальность</bold><bold>.</bold> Исследования этиологии и патогенеза ладонного фасциального фиброматоза вплоть до настоящего времени остаются актуальными, однако данные о гистогенетической природе его быстрого прогрессирования и гистологических предикторах рецидивирования в литературе отсутствуют.</p> <p><bold>Цель исследования </bold>— сравнительный анализ тканевого состава и перфорантных артерий ладонного апоневроза у пациентов с быстрым и типичным развитием контрактуры Дюпюитрена.</p> <p><bold>Материал и методы.</bold> Проанализировано 222 истории болезни пациентов, прооперированных в период с 2014 по 2019 г. Срок формирования контрактуры Дюпюитрена (КД) в наиболее многочисленной группе (n = 88) — от трех до восьми лет — был определен как типичный; развитие КД за два года и менее (n = 41) интерпретировано как быстрое. Была проведена гистоморфометрия операционного материала при быстром (n = 20, группа 1) и типичном (n = 25, группа 2) прогрессировании КД. В качестве сравнения с нормой были использованы иссеченные при хирургической обработке ран кисти фрагменты ладонного апоневроза условно здоровых людей (n = 5).</p> <p><bold>Результаты. </bold>Медиана содержания гиперпластической соединительной ткани статистически значимо больше в группе 1 (p &lt; 0,05), но показатель широко варьирует в обеих группах. В группе 1 была выявлена статистически значимо бо́льшая процентная доля содержания сосудов микроциркуляторного русла, в том числе патологически измененных и новообразующихся (CD34+). Гистоморфометрия перфорантных артерий ладонного апоневроза показала, что в артериях среднего калибра у пациентов групп 1 и 2 по сравнению с нормой наружный диаметр больше на 4% (p &lt; 0,05) и 12,5% (p &lt; 0,01) соответственно; диаметры просветов в группе 1 меньше на 30% (p &lt; 0,01), а в группе 2 больше на 31% (p &gt; 0,05). В артериях крупного калибра в группах 1 и 2 наружный диаметр по сравнению с контролем был меньше на 18% (p &lt; 0,01) и 17% (p &gt; 0,05), а диаметры просветов — меньше на 52% (p = 0,00) и 18% (p &gt; 0,05) соответственно.</p> <p><bold>Заключение.</bold> Несмотря на меньшую давность заболевания, у пациентов с быстрым прогрессированием контрактуры Дюпюитрена выявлено увеличение численности патологически измененных сосудов микроциркуляторного русла и более выраженное стенотическое ремоделирование перфорантных артерий ладонного апоневроза, что верифицирует раннее сосудистое старение. Гистологические предикторы послеоперационного рецидивирования необходимо оценивать индивидуально.</p></trans-abstract><trans-abstract xml:lang="zh"><p/></trans-abstract><kwd-group xml:lang="en"><kwd>palmar fascial fibromatosis</kwd><kwd>Dupuytren’s contracture</kwd><kwd>arterial remodeling</kwd><kwd>vascular aging</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>ладонный фасциальный фиброматоз</kwd><kwd>контрактура Дюпюитрена</kwd><kwd>ремоделирование артерий</kwd><kwd>сосудистое старение</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>Phan R., Hunter-Smith D.J., Rozen W.M. Recent Australian contributions to the management of Dupuytren’s disease. Australas J Plast Surg. 2020;3(1): 39-46. https://doi.org/10.34239/ajops.v3n1.151.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Идрисов Х.К., Родоманова Л.А. Восполнение дефицита кожного покрова после субтотальной апоневрэктомии при контрактуре Дюпюитрена тяжелой степени: обзор литературы. Травматология и ортопедия России. 2022;28(2):114-123. https:// doi.org/10.17816/2311-2905-1767. Idrisov Kh.K., Rodomanova L.A. Skin Closure After Subtotal Aponeurectomy in Severe Dupuytren’s Contracture: Review. Traumatology and Orthopedics of Russia. 2022;28(2):114-123. (In Russian). https:// doi.org/10.17816/2311-2905-1767.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Wilburn J., McKenna S.P., Perry-Hinsley D., Bayat A. The impact of Dupuytren disease on patient activity and quality of life. J Hand Surg Am. 2013;38(6):1209-1214. https://doi.org/10.1016/j.jhsa.2013.03.036.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Trojian T.H., Chu S.M. Dupuytren’s disease: diagnosis and treatment. Am Fam Physician. 2007;76(1):86-89.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>van Straalen R.J.M., de Boer M.R., Vos F., Werker P.M.N., Broekstra D.C. The incidence and prevalence of Dupuytren’s disease in primary care: results from a text mining approach on registration data. Scand J Prim Health Care. 2025;43(1):173-180. https://doi.org/10.1080/02813432.2024.2416678.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Salari N., Heydari M., Hassanabadi M., Kazeminia M., Farshchian N., Niaparast M. et al. The worldwide prevalence of the Dupuytren disease: a comprehensive systematic review and meta-analysis. J Orthop Surg Res. 2020;15(1):495. https:// doi.org/10.1186/s13018-020-01999-7.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Morelli I., Fraschini G., Banfi A.E. Dupuytren’s Disease: Predicting Factors and Associated Conditions. A Single Center Questionnaire-Based Case-Control Study. Arch Bone Jt Surg. 2017;5(6):384-393.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Nilsson T., Wahlström J., Reierth E., Burström L. Dupuytren’s Disease in Relation to the Exposure to Hand-Transmitted Vibration: A Systematic Review and Meta-Analysis. Proceedings. 2023;86(1):30. https:// doi.org/10.3390/proceedings2023086030.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Ruettermann M., Hermann R.M., Khatib-Chahidi K., Werker P.M.N. Dupuytren’s Disease-Etiology and Treatment. Dtsch Arztebl Int. 2021;118(46):781-788. https://doi.org/10.3238/arztebl.m2021.0325.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>O’Gorman D.B., Vi L., Gan B.S. Molecular mechanisms and treatment strategies for Dupuytren’s disease. Ther Clin Risk Manag. 2010;6:383-390. https:// doi.org/10.2147/tcrm.s9165.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Ball C., Izadi D., Verjee L.S., Chan J., Nanchahal J. Systematic review of non-surgical treatments for early dupuytren’s disease. BMC Musculoskelet Disord. 2016;17(1):345. https:// doi.org/10.1186/s12891-016-1200-y.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Rijssen A.L., Ter Linden H., Werker P.M.N. Five-year results of a randomized clinical trial on treatment in Dupuytren’s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast Reconstr Surg. 2012;129(2):469-477. https:// doi.org/10.1097/PRS.0b013e31823aea95.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Reilly R.M., Stern P.J., Goldfarb C.A. A retrospective review of the management of Dupuytren’s nodules. J Hand Surg Am. 2005;30(5):1014-1018. https:// doi.org/10.1016/j.jhsa.2005.03.005.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Townley W.A., Baker R., Sheppard N., Grobbelaar A.O. Dupuytren’s contracture unfolded. BMJ. 2006;332(7538):397-400. https:// doi.org/10.1136/bmj.332.7538.397.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Gudmundsson K.G., Arngrimsson R., Jónsson T. Eighteen years follow-up study of the clinical manifestations and progression of Dupuytren’s disease. Scand J Rheumatol. 2001;30(1):31-34. https:// doi.org/10.1080/030097401750065292.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Bayat A., McGrouther D.A. Management of Dupuytren’s disease-clear advice for an elusive condition. Ann R Coll Surg Engl. 2006;88(1):3-8. https:// doi.org/10.1308/003588406X8310.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Dumitrescu-Ionescu D. A New Therapeutic Approach to Dupuytren’s Contracture / Disease (DD). Adv Plast Reconstr Surg. 2017;1(5):129-136.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Dutta A., Jayasinghe G., Deore S., Wahed K., Bhan K., Bakti N. et al. Dupuytren’s Contracture – Current Concepts. J Clin Orthop Trauma. 2020;11(4):590-596. https://doi.org/10.1016/j.jcot.2020.03.026.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Warren R.F. The pathology of Dupuytren’s contracture. Br J Plast Surg. 1953;6(3):224-230.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>MacCallum S.P., Hueston J.T. The pathology of Dupuytren’s contracture. ANZ J Surg. 1962;31(4):241-253. https://doi.org/10.1111/j.1445-2197.1962.tb03271.x.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>Balaguer T., David S., Ihrai T., Cardot N., Daideri G., Lebreton E. Histological staging and Dupuytren’s disease recurrence or extension after surgical treatment: a retrospective study of 124 patients. J Hand Surg Eur Vol. 2009;34(4):493-496. https:// doi.org/10.1177/1753193409103729.</mixed-citation></ref><ref id="B22"><label>22.</label><mixed-citation>Alfonso-Rodríguez C.A., Garzón I., Garrido-Gómez J., Oliveira A.C., Martín-Piedra M.Á., Scionti G. et al. Identification of histological patterns in clinically affected and unaffected palm regions in dupuytren’s disease. PLoS One. 2014;9(11):e112457. https:// doi.org/10.1371/journal.pone.0112457.</mixed-citation></ref><ref id="B23"><label>23.</label><mixed-citation>Zhang A.Y., Kargel J.S. The Basic Science of Dupuytren Disease. Hand Clin. 2018;34(3):301-305. https:// doi.org/10.1016/j.hcl.2018.03.001.</mixed-citation></ref><ref id="B24"><label>24.</label><mixed-citation>Shum D.T. Histopathology. In: McFarlane P.M., McGrouther D.A., Flint M.H. (eds). Dupuytren’s disease. New York: Churchill Livingstone; 1990. p. 25-30.</mixed-citation></ref><ref id="B25"><label>25.</label><mixed-citation>Долганова Т.И., Щудло Н.А., Шабалин Д.А., Костин В.В. Оценка гемодинамики артерий кисти и микроциркуляции кожи при контрактуре Дюпюитрена 3–4 стадий до и после оперативного лечения с применением чрескостной фиксации по Г.А. Илизарову. Гений ортопедии. 2019;25(1):86-92. https://doi.org/10.18019/1029-4427-2019-25-1-86-92. Dolganova T.I., Shchudlo N.A., Shabalin D.A., Kostin V.V. Assessment of hemodynamics of the hand arteries and skin microcirculation in Dupuytren’s contracture stages 3 to 4 of before and after surgical treatment with the use of Ilizarov transosseous fixation. Genij Ortopedii. 2019;25(1):86-92. (In Russian). https://doi.org/10.18019/1029-4427-2019-25-1-86-92.</mixed-citation></ref><ref id="B26"><label>26.</label><mixed-citation>Щудло Н.А., Варсегова Т.Н., Ступина Т.Н., Щудло М.М. Типы и стадии сосудистого ремоделирования при контрактуре Дюпюитрена (анализ 506 артерий в операционном материале 111 пациентов). Гений ортопедии. 2020;26(2):179-184. https:// doi.org/10.18019/1028-4427-2020-26-2-179-184. Shchudlo N.A., Varsegova T.N., Stupina T.A., Shchudlo M.M. Types and stages of vascular remodeling in Dupuytren’s contracture (analysis of 506 arteries in the surgical material of 111 patients). Genij Ortopedii. 2020;26(2):179-184. (In Russian). https:// doi.org/10.18019/1028-4427-2020-26-2-179-184.</mixed-citation></ref><ref id="B27"><label>27.</label><mixed-citation>Nilsson P.M. Early vascular aging (EVA): consequences and prevention. Vasc Health Risk Manag. 2008;4(3):547-552. https://doi.org/10.2147/vhrm.s1094.</mixed-citation></ref><ref id="B28"><label>28.</label><mixed-citation>Евсевьева М.Е., Ерёмин М.В., Ростовцева М.В., Сергеева О.В., Фурсова Е.Н., Русиди А.В. и др. Фенотипы преждевременного и благоприятного сосудистого старения у лиц молодого возраста с учетом профиля факторов риска и признаков дисплазии соединительной ткани. Кардиоваскулярная терапия и профилактика. 2020;19(6):2524. https:// doi.org/10.15829/1728-8800-2020-2524. Evseveva M.E., Eremin M.V., Rostovtseva M.V., Sergeeva O.V., Fursova E.N., Rusidi V.A. et al. Phenotypes of early and favorable vascular aging in young people depending on the risk factors and presence of connective tissue dysplasia. Cardiovascular Therapy and Prevention. 2020;19(6):2524. (In Russian). https:// doi.org/10.15829/1728-8800-2020-2524.</mixed-citation></ref><ref id="B29"><label>29.</label><mixed-citation>Рудой М.Д. Распространенность синдрома раннего сосудистого старения у мужчин, работающих в условиях воздействия шума. Архивъ внутренней медицины. 2024;14(1):72-80. https:// doi.org/10.20514/2226-6704-2024-14-1-72-80. Rudoi M.D. Prevalence of Early Vascular Aging Syndrome in Men Working Under Noise Exposure. The Russian Archives of Internal Medicine. 2024;14(1):72-80. (In Russian). https://doi.org/10.20514/2226-6704-2024-14-1-72-80.</mixed-citation></ref><ref id="B30"><label>30.</label><mixed-citation>Merz A.A., Cheng S. Sex differences in cardiovascular ageing. Heart. 2016;102(11):825-831. https:// doi.org/10.1136/heartjnl-2015-308769.</mixed-citation></ref><ref id="B31"><label>31.</label><mixed-citation>Calandruccio J.H. Dupuytren’s contracture. In: Azar F.M., Beaty J.H., Canale S.T. (eds). Campbell’s Operative Orthopaedics. St. Louis, MO: Elsevier; 2017. p. 3734-3749.</mixed-citation></ref><ref id="B32"><label>32.</label><mixed-citation>Mathieu S., Pereira B., Dutheil F., Tournadre A., Soubrier M. Cardiovascular Risk Profile in Dupuytren’s Disease: A Systematic Review and Meta-Analysis. Cardiol Cardiovasc Med. 2024;8(5):440-454. https:// doi.org/10.26502/fccm.92920405.</mixed-citation></ref><ref id="B33"><label>33.</label><mixed-citation>Broekstra D.C., Kuo R.Y.L., Burn E., Prieto-Alhambra D., Furniss D. Dupuytren Disease: Prevalence, Incidence, and Lifetime Risk of Surgical Intervention. A Population-Based Cohort Analysis. Plast Reconstr Surg. 2023;151(3):581-591. https:// doi.org/10.1097/PRS.0000000000009919.</mixed-citation></ref><ref id="B34"><label>34.</label><mixed-citation>Жигало А.В., Почтенко В.В., Морозов В.В., Березин П.А., Баранов В.В., Наконечный Д.Г. и др. Особенности хирургической тактики лечения больных с контрактурой Дюпюитрена (наш опыт). Вопросы реконструктивной и пластической хирургии. 2024;27(1):70-81. https:// doi.org/10.52581/1814-1471/88/07. Zhigalo А.V., Pochtenko V.V., Morozov V.V., Berezin Р.А., Baranov V.V., Nakonechny D.G. et al. Pecial features of surgical approach for patients with Dupuytren’s contracture (our experience). Issues of Reconstructive and Plastic Surgery. 2024;27(1):70-81. (In Russian). https://doi.org/10.52581/1814-1471/88/07.</mixed-citation></ref></ref-list></back></article>
